The Involvement of Metal Ions in Alzheimerï¾ s Disease Pathology and Implications for Diagnosis and Treatment
Year: 2011
Type: dissertation
Abstract: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder and is by far the most prevalent form of dementia in the U.S. Physically, it is characterized by cortical atrophy, neurodegeneration, and the accumulation of neurofibrillary tangles and amyloid beta (Aβ) plaques in the cortex and hippocampus.Imbalances of metal ions such as iron (Fe), copper (Cu), and zinc (Zn), which are present in the brain normally, have also been observed in AD brain, but the role of metal ions in the manifestation of the disease remains unclear.Therefore, the goal of this dissertation was to determine how metal homeostasis in the hippocampus, cortex, and in amyloid plaques is affected in a PSAPP transgenic mouse model of plaque formation in AD as a function of age.We examined plaques in PSAPP at four time points representing four stages of plaque formation in AD, from pre-AD to late-AD.Results showed that Cu and Fe were not elevated in the mouse plaques at any time point, but were elevated in Zn at the late-AD time point.This is in contrast to endstage human AD plaques, which were enriched in all metals, but especially Cu.Since Cu can be neurotoxic, this finding may explain the lack of severe neurodegeneration in PSAPP mice that is a signature of human AD.We then examined the metal ion content in the cortex and hippocampus, two regions affected by plaque formation in human AD, in PSAPP mice as they aged.iv Results showed that in both the hippocampus and cortex Zn was elevated only at the late-AD time point.Since the plaques were also elevated in Zn only at the late-AD time point, this implies that Zn is not involved in plaque formation, but could hold a protective role.Interestingly, even though Fe was absent from the PSAPP plaques, the Fe content in both the cortex and hippocampus was increased from early time points.Thus, the lack of Fe in plaques implies that the elevated Fe observed in non-plaque tissue arises not from an interaction with Aβ, but from some other mechanism.For example, increased Fe could result from disruption in the expression of other brain Fe regulatory, transport, or storage proteins.Since excess Fe can contribute to lipid peroxidation and damage to unsaturated lipids in the brain, we also examined the unsaturated lipid content of the hippocampus.We found that the changes in Fe content in the hippocampus were accompanied by reduced unsaturated lipid content in hippocampal white matter, which may be evidence for lipid peroxidation.Taken together, these results suggest that early increases in Fe and damage to white matter reflect pathological changes related to plaque formation in PSAPP mice and that Fe deposition could be a promising biomarker to predict early plaque deposition.Moreover, the absence of Cu and Fe in PSAPP plaques, which are abundant in human plaques, provides a solid path to follow for future research to identify target for drug development or metal-targeted therapy.
Author: Leskovjan, Andreana
Institution: Stony Brook University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6982605921
